GLP1R and pseudotumor cerebri: Glucagon‐like peptide‐1 receptor (GLP‐1R) agonists, which lower cerebrospinal fluid (CSF) production, have shown success in idiopathic intracranial hypertension (IIH) by reducing ICP and improving headache frequency.